PREDNIDERM
PREDNIDERM
Authorised
- NEOMYCIN SULFATE
- Prednisolone acetate
Product identification
Medicine name:
PREDNIDERM
Active substance:
- NEOMYCIN SULFATE
- Prednisolone acetate
Target species:
-
Dog
-
Cat
-
Horse
-
Horse (mare)
Route of administration:
-
Cutaneous use
Product details
Active substance and strength:
-
NEOMYCIN SULFATE3333.33/international unit(s)1.00gram(s)
-
Prednisolone acetate1.49/milligram(s)1.00gram(s)
Pharmaceutical form:
-
Cutaneous emulsion
Withdrawal period by route of administration:
-
Cutaneous use
-
Horse
-
Meat and offal0day
-
-
Horse (mare)
-
Milkno withdrawal periodEn l'absence de LMR pour le lait, ne pas utiliser chez les femelles productrices de lait de consommation, en lactation ou en période de tarissement ni chez les futures productrices de lait de consommation dans les 2 mois qui précèdent la mise-bas.
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QD07CA03
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
France
Available in:
-
France
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Vetoquinol S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Vetoquinol S.A.
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/5586846 8/1988
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 11/09/2025
Package Leaflet and Labelling
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 15/10/2025
